NASDAQ:INVA
Innoviva, Inc.
- Stock
locale
United Statesmarket
STOCKSindustry
Biotechnologywebsite
www.inva.comipo date
Oct 05, 2004
Innoviva, Inc. engages in the development and commercialization of pharmaceuticals in the United States and internationally. Its products include RELVAR/BREO ELLIPTA, a once-daily combination medicine consisting of a LABA, vilanterol (VI), an inhaled corticosteroid (ICS), and fluticasone furoate; ANORO ELLIPTA, a once-daily medicine combining a long-acting muscarinic antagonist...Show More
Earnings
Earnings Release in 4 daysEarnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus